Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    The Janus Corner

    The Janus Corner

    Web AdminBy Web AdminOctober 12, 2022Updated:October 12, 2022No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    I E Cock1,2,*
    1School of Environment and Science, Nathan Campus, Griffith University, Brisbane, Queensland, AUSTRALIA.
    2Centre for Planetary Health and Food Security, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    DOI: 10.5530/pc.2022.4.30

    ABSTRACT

    Whilst the range of SARS-CoV-2 vaccines introduced globally since the start of the current pandemic have dramatically reduced the adverse effects of the disease and stemmed the spread of the virus, there is still a need for chemotherapies to relieve the symptoms of the disease and to further decrease its spread. Traditional medicines may provide drug leads to treat COVID-19 and I have previously highlighted several plant species with promising bioactivities relevant to COVID-19 in this forum.1 However, the antiviral potential of marine natural products have been largely overlooked. A recent study by a Georgia Institute of Technology research team that was published in the Journal of Natural Products screened an extensive library of natural compounds against SARS-CoV-2 replication in animal cell lines. The group prioritised library compounds that are structurally similar to known antiviral compounds, particularly those with reported activity against other coronaviruses and other RNA viruses.2 Of the library of compounds tested, three were deemed to be particularly promising. The lead compounds were structurally diverse, with a β-carboline alkaloid, a sesquiterpenoid hydroquinone and a mero-diterpenoid macrolide identified, each with noteworthy anti- SARS-CoV-2 activity. Further studies are required to further quantify the antiviral activity of these compounds and to determine their antiviral mechanism.  Read more…

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up